Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease)
- PMID: 15607407
- DOI: 10.1016/j.jacc.2004.09.029
Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease)
Similar articles
-
Factors affecting the long-term outcome of Buerger's disease (thromboangiitis obliterans).Int Angiol. 1999 Mar;18(1):58-64. Int Angiol. 1999. PMID: 10392482
-
[Experimental-surgical aspect of Buerger's disease and its hyperpyretic therapy. Clinical experiences with partial salvage amputation of the lower limbs on a demarcation zone in Buerger's disease].Med Arh. 1974 Jul-Aug;28(4):369-75. Med Arh. 1974. PMID: 4444348 Serbian. No abstract available.
-
Successful Percutaneous Transcatheter Angioplasty of Radial Artery in Thromboangiitis Obliterans (Buerger's Disease).JACC Cardiovasc Interv. 2017 Nov 27;10(22):e205-e206. doi: 10.1016/j.jcin.2017.06.066. Epub 2017 Sep 13. JACC Cardiovasc Interv. 2017. PMID: 28917511 No abstract available.
-
Pharmacological treatment for Buerger's disease.Cochrane Database Syst Rev. 2020 May 4;5(5):CD011033. doi: 10.1002/14651858.CD011033.pub4. Cochrane Database Syst Rev. 2020. PMID: 32364620 Free PMC article.
-
Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease).Vasc Endovascular Surg. 2018 Feb;52(2):124-130. doi: 10.1177/1538574417744085. Epub 2017 Dec 13. Vasc Endovascular Surg. 2018. PMID: 29237360 Review.
Cited by
-
Buerger's disease presenting as a testicular mass: A rare presentation of an uncommon disease.Urol Ann. 2016 Apr-Jun;8(2):249-51. doi: 10.4103/0974-7796.179238. Urol Ann. 2016. PMID: 27141205 Free PMC article.
-
Therapeutic angiogenesis in Buerger's disease: reviewing the treatment landscape.Ther Adv Rare Dis. 2022 Jan 30;3:26330040211070295. doi: 10.1177/26330040211070295. eCollection 2022 Jan-Dec. Ther Adv Rare Dis. 2022. PMID: 37180424 Free PMC article. Review.
-
Cilostazol on the expression of ICAM-1, VCAM-1 and inflammatory factors in plasma in patients with thromboangiitis obliterans.Exp Ther Med. 2018 Sep;16(3):2349-2354. doi: 10.3892/etm.2018.6436. Epub 2018 Jul 11. Exp Ther Med. 2018. PMID: 30186478 Free PMC article.
-
Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients.J Am Heart Assoc. 2018 Dec 4;7(23):e010677. doi: 10.1161/JAHA.118.010677. J Am Heart Assoc. 2018. PMID: 30571594 Free PMC article.
-
Long-term outcomes and prognostic factors of major amputation in thromboangiitis obliterans after drug therapy and endovascular procedures: A real-world cohort study.Sci Prog. 2025 Jan-Mar;108(1):368504251320766. doi: 10.1177/00368504251320766. Sci Prog. 2025. PMID: 40025902 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources